Title |
STING Protein‐Based In Situ Vaccine Synergizes CD4+ T, CD8+ T, and NK Cells for Tumor Eradication
|
---|---|
Published in |
Advanced Healthcare Materials, April 2023
|
DOI | 10.1002/adhm.202300688 |
Pubmed ID | |
Authors |
Yanpu He, Celestine Hong, Shengnan Huang, Justin A. Kaskow, Gil Covarrubias, Ivan S. Pires, James C. Sacane, Paula T. Hammond, Angela M. Belcher |
Abstract |
Stimulator of interferon genes (STING) signaling is a promising target in cancer immunotherapy, with many ongoing clinical studies in combination with immune checkpoint blockade (ICB). Existing STING-based therapies largely focus on activating CD8+ T cell or NK cell-mediated cytotoxicity, while the role of CD4+ T cells in STING signaling has yet to be extensively studied in vivo. Here, we report a distinct CD4-mediated, protein-based combination therapy of STING and ICB as an in situ vaccine. The treatment eliminated subcutaneous MC38 and YUMM1.7 tumors in 70%-100% of mice and protected all cured mice against rechallenge. Mechanistic studies revealed a robust TH 1 polarization and suppression of Treg of CD4+ T cells, followed by an effective collaboration of CD4+ T, CD8+ T and NK cells to eliminate tumors. Finally, we demonstrated the potential to overcome host STING deficiency by significantly decreasing MC38 tumor burden in STING-KO mice, addressing the translational challenge for the 19% of human population with loss-of-function STING variants. This article is protected by copyright. All rights reserved. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 4 | 16% |
Paraguay | 1 | 4% |
India | 1 | 4% |
Ireland | 1 | 4% |
France | 1 | 4% |
Unknown | 17 | 68% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 17 | 68% |
Scientists | 5 | 20% |
Practitioners (doctors, other healthcare professionals) | 2 | 8% |
Science communicators (journalists, bloggers, editors) | 1 | 4% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 9 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 3 | 33% |
Other | 2 | 22% |
Researcher | 1 | 11% |
Unknown | 3 | 33% |
Readers by discipline | Count | As % |
---|---|---|
Biochemistry, Genetics and Molecular Biology | 2 | 22% |
Agricultural and Biological Sciences | 1 | 11% |
Medicine and Dentistry | 1 | 11% |
Materials Science | 1 | 11% |
Engineering | 1 | 11% |
Other | 0 | 0% |
Unknown | 3 | 33% |